Temporary Neurotoxin Treatment to Prevent Postop AFib
Dr. C. Michael Gibson discusses the trial findings with Dr. Nathan Waldron at AHA 2017
ALLSTAR: ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration
Dr. Timothy Henry and Dr. C. Michael Gibson Discuss
STEMI ACCELERATOR-2 – Regional STEMI Systems of Care
Dr. Christopher Granger, Dr. James Jollis and Dr. C. Michael Gibson Discuss
Opportunities to Improve Outcomes for CV Emergencies in the US
Ms. Mayme Roettig, Dr. James Jollis, Dr. Christopher Granger, Dr. Timothy Henry and Dr. C. Michael Gibson Discuss
Continued versus Interrupted NOAC at the time of Device Surgery
Dr. David Birnie and Dr. C. Michael Gibson Discuss
Critical Analysis from the CANTOS Trial
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: CANTOS - Residual Inflammatory Risk and Residual Cholesterol Risk
Does High-Intensity Pitavastatin Therapy Improve Clinical Outcomes?
Dr. Takeshi Kimura and Dr. C. Michael Gibson Discuss REAL-CAD - Does High-Intensity Pitavastatin Therapy Further Improve Clinical Outcomes?
Does intensive statin lowering therapy in diabetic retinopathy reduce CV events?
Dr. Hiroshi Itoh and Dr. Rim Halaby discuss
ESC 2017 Wrap-Up from a Scandinavian Perspective
Dr. Jonas Oldgren, Dr. Stephen James and Dr. Robin Hofmann Present
CV Outcomes for People using Anticoagulation Strategies (COMPASS) trial
Dr. C. Michael Gibson discusses the trial findings with Dr. John Eikelboom at ESC 2017
SPYRAL HTN OFF-MED Study
Dr. C. Michael Gibson discusses the trial findings with Dr. Michael Boehm at ESC 2017